norethindrone has been researched along with c-peptide in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
Bard, JM; Djøseland, O; Fruchart, JC; Gørbitz, C; Ose, L; Tonstad, S | 1 |
Cooper, AJ; Godsland, IF; Ross, D; Spencer, CP; Stevenson, JC; Whitehead, MI | 1 |
Arce, JC; Cyrowski, MS; Davidson, MH; Maki, AC; Maki, KC; Marx, P; Nanavati, N | 1 |
Godsland, IF; Manassiev, N; Proudler, AJ; Stevenson, JC; Whitehead, MI | 1 |
4 trial(s) available for norethindrone and c-peptide
Article | Year |
---|---|
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women.
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol, LDL; Combined Modality Therapy; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hypercholesterolemia; Insulin; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome | 1995 |
Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; C-Peptide; Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Middle Aged; Models, Theoretical; Norethindrone; Norethindrone Acetate; Pancreas; Postmenopause | 2000 |
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Topics: Aged; Apolipoprotein A-I; Blood Coagulation Factors; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Lipoprotein(a); Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors; Treatment Outcome; Triglycerides | 2000 |
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
Topics: Aged; Blood Glucose; C-Peptide; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Humans; Insulin; Insulin Resistance; Middle Aged; Norethindrone; Norpregnenes | 2013 |
3 other study(ies) available for norethindrone and c-peptide
Article | Year |
---|---|
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |